Chad Conner
Chief Operating Officer bei HOMETOWN INTERNATIONAL, INC.
Profil
Chad S.
Conner is currently the Chief Executive Officer & Director at Mycrodose Therapeutics, Inc. since 2020 and the Chief Operating Officer at Makamer Holdings, Inc. since 2022.
Previously, he served as the Chief Executive Officer & Director at Pure Ratios Holdings, Inc. from 2015 to 2021.
Aktive Positionen von Chad Conner
| Unternehmen | Position | Beginn |
|---|---|---|
| HOMETOWN INTERNATIONAL, INC. | Chief Operating Officer | 01.04.2022 |
Mycrodose Therapeutics, Inc.
 Mycrodose Therapeutics, Inc. BiotechnologyHealth Technology Mycrodose Therapeutics, Inc. is a US-based pharmaceutical company that specializes in developing advanced drug delivery systems using DEA Schedule I & III drugs and other compounds to treat cancer-related conditions, mental health, and cognitive degenerative diseases. Mycrodose Therapeutics is one of the few private companies that have been granted a Schedule I license and approved by the United States Drug Enforcement Agency (DEA), State of Attorney Generals Research Advisory Board, and the US Food & Drug Administration (FDA) to research four psychedelic compounds: psilocybin, LSD, MDMA, and DMT. The company is based in San Diego, CA, and was founded in 2020. The company's IP-protected sustained microdosing technology™ is a safer and smarter approach to delivering pharmaceutical compounds to patients of all ages, allowing for an expandable and scalable business model. Chad S. Conner has been the CEO of the company since 2020. | Chief Executive Officer | 01.11.2020 |
Ehemalige bekannte Positionen von Chad Conner
| Unternehmen | Position | Ende |
|---|---|---|
Pure Ratios Holdings, Inc.
 Pure Ratios Holdings, Inc. Pharmaceuticals: OtherHealth Technology Pure Ratios Holdings, Inc. develops and manufactures traditional Chinese medicines with cannabis including the integration of hemp derived CBD. The company was founded by William A. Conner in 2015 and is headquartered in San Diego, CA. | Chief Executive Officer | 01.03.2021 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HOMETOWN INTERNATIONAL, INC. | Retail Trade |
| Private Unternehmen | 2 |
|---|---|
Pure Ratios Holdings, Inc.
Pure Ratios Holdings, Inc. Pharmaceuticals: OtherHealth Technology Pure Ratios Holdings, Inc. develops and manufactures traditional Chinese medicines with cannabis including the integration of hemp derived CBD. The company was founded by William A. Conner in 2015 and is headquartered in San Diego, CA. | Health Technology |
Mycrodose Therapeutics, Inc.
Mycrodose Therapeutics, Inc. BiotechnologyHealth Technology Mycrodose Therapeutics, Inc. is a US-based pharmaceutical company that specializes in developing advanced drug delivery systems using DEA Schedule I & III drugs and other compounds to treat cancer-related conditions, mental health, and cognitive degenerative diseases. Mycrodose Therapeutics is one of the few private companies that have been granted a Schedule I license and approved by the United States Drug Enforcement Agency (DEA), State of Attorney Generals Research Advisory Board, and the US Food & Drug Administration (FDA) to research four psychedelic compounds: psilocybin, LSD, MDMA, and DMT. The company is based in San Diego, CA, and was founded in 2020. The company's IP-protected sustained microdosing technology™ is a safer and smarter approach to delivering pharmaceutical compounds to patients of all ages, allowing for an expandable and scalable business model. Chad S. Conner has been the CEO of the company since 2020. | Health Technology |
